Publications by authors named "Klaus Lechner"

Claim this Profile
A
Acquired C1 esterase inhibitor deficiency in lymphomas: prevalence, symptoms, and response to treatment.
Christine Bekos, Thomas Perkmann, Maria Krauth, Markus Raderer, Klaus Lechner

Leuk Lymphoma· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Probability of remaining in unsustained complete remission after steroid therapy withdrawal in patients with primary warm-antibody reactive autoimmune hemolytic anemia.
Johanna Kulpa, Cathrin Skrabs, Ralph Simanek, Peter Valent, Simon Panzer, Klaus Lechner

Wien Klin Wochenschr· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Interleukin-10 inhibits autonomous myelopoiesis in patients with myelofibrosis.
Klaus Geissler, Eva Jäger, Leopold Öhler, Heinz Gisslinger, Ulrich Jäger, Klaus Lechner

Eur J Haematol· September 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Explaining survival differences between two consecutive studies with allogeneic stem cell transplantation in patients with chronic myeloid leukemia.
Markus Pfirrmann, Susanne Saussele, Andreas Hochhaus, Andreas Reiter, Ute Berger, Klaus Lechner

J Cancer Res Clin Oncol· August 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cold antibody autoimmune hemolytic anemia and lymphoproliferative disorders: a retrospective study of 20 patients including clinical, hematological, and molecular findings.
Cathrin Arthold, Cathrin Skrabs, Gerlinde Mitterbauer-Hohendanner, Renate Thalhammer, Ingrid Simonitsch-Klupp, Klaus Lechner

Wien Klin Wochenschr· June 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune-mediated disorders causing bleeding or thrombosis in lymphoproliferative diseases.
Klaus Lechner, Ingrid Pabinger, Hanna Lena Obermeier, Paul Knoebl

Semin Thromb Hemost· April 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cancer-related microangiopathic hemolytic anemia: clinical and laboratory features in 168 reported cases.
Klaus Lechner, Hanna Lena Obermeier

Medicine (Baltimore)· July 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibitor development in two patients with mild haemophilia A - spontaneous disappearance and no recurrence of the inhibitor after re-challenge.
Sylvia Reitter-Pfoertner, Birgit Horvath, Klaus Lechner, Raute Sunder-Plassmann, Christine Mannhalter

Wien Klin Wochenschr· March 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Paraneoplastic autoimmune thrombocytopenia in solid tumors.
Maria-Theresa Krauth, Joe Puthenparambil, Klaus Lechner

Crit Rev Oncol Hematol· January 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Acquired immune-mediated thrombophilia in lymphoproliferative disorders.
Klaus Lechner, Ingrid Simonitsch, Johanna Haselböck, Ulrich Jäger, Ingrid Pabinger

Leuk Lymphoma· October 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improved outcome in patients with chronic myelogenous leukemia after allogeneic hematopoietic stem cell transplantation over the past 25 years: a single-center experience.
Alexandra Boehm, Barbara Walcherberger, Wolfgang R Sperr, Stefan Wöhrer, Karin Dieckmann, Klaus Lechner

Biol Blood Marrow Transplant· January 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
How I treat autoimmune hemolytic anemias in adults.
Klaus Lechner, Ulrich Jäger

Blood· September 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Autoimmune hemolytic anemia as a paraneoplastic phenomenon in solid tumors: A critical analysis of 52 cases reported in the literature.
Joe Puthenparambil, Klaus Lechner, Gabriela Kornek

Wien Klin Wochenschr· April 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Paraneoplastic autoimmune cytopenias in Hodgkin lymphoma.
Klaus Lechner, Yen-An Chen

Leuk Lymphoma· March 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group.
Francesco Rodeghiero, Roberto Stasi, Terry Gernsheimer, Marc Michel, Drew Provan, Klaus Lechner

Blood· March 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The postoperative splenic/portal vein thrombosis after splenectomy and its prevention--an unresolved issue.
Maria-Theresa Krauth, Klaus Lechner, Edmund A M Neugebauer, Ingrid Pabinger

Haematologica· August 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diagnosis and treatment of autoimmune haemolytic anaemias in adults: a clinical review.
Peter Valent, Klaus Lechner

Wien Klin Wochenschr· July 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Autoimmune thrombocytopenia in non-Hodgkin's lymphomas.
Alexander W Hauswirth, Cathrin Skrabs, Christian Schützinger, Markus Raderer, Andreas Chott, Klaus Lechner

Haematologica· March 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk of recurrence after a first venous thromboembolic event in young women.
Clarissa Laczkovics, Helga Grafenhofer, Alexandra Kaider, Peter Quehenberger, Ralph Simanek, Klaus Lechner

Haematologica· September 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Drug treatment is superior to allografting as first-line therapy in chronic myeloid leukemia.
Rüdiger Hehlmann, Ute Berger, Markus Pfirrmann, Hermann Heimpel, Andreas Hochhaus, Klaus Lechner

Blood· June 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Autoimmune hemolytic anemias, Evans' syndromes, and pure red cell aplasia in non-Hodgkin lymphomas.
Alexander W Hauswirth, Cathrin Skrabs, Christian Schützinger, Alexander Gaiger, Klaus Lechner

Leuk Lymphoma· June 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rituximab for the treatment of acquired antibodies to factor VIII.
Wolfgang R Sperr, Klaus Lechner, Ingrid Pabinger

Haematologica· January 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The course of severe autoimmune thrombocytopenia in patients not undergoing splenectomy.
Thomas Sailer, Klaus Lechner, Simon Panzer, Paul Alexander Kyrle, Ingrid Pabinger

Haematologica· August 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Adult autoimmune thrombocytopenia: diagnosis and treatment].
Klaus Lechner, Ansgar Weltermann, Ingrid Pabinger

Wien Klin Wochenschr· May 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Vitamin B12 deficiency. New data on an old theme].
Klaus Lechner, Manuela Födinger, Wolfgang Grisold, Andreas Püspök, Christian Sillaber

Wien Klin Wochenschr· September 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis